Maaike Esselaar

Maaike Esselaar

Auto-generated profile, based on publicly available information

Maaike Esselaar

Manchester Metropolitan University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2024 in Journal of Sport and Exercise Psychology
Verified
Journal Article
Closed access
PDF file
MSMatthew W. Scott
Matthew W. Scott
MEMaaike Esselaar
Maaike Esselaar
NNNeil NDagnall
Neil NDagnall
ADAndrew Denovan
Andrew Denovan
BMBen Marshall
Ben Marshall
DWDavid J. Wright
David J. Wright
Combined use of action observation and motor imagery (AOMI) is an increasingly popular motor-simulation intervention, which involves observing movements on video while simultaneously imagining the feeling of movement execution. Measuring and reporting participant imagery-ability characteristics are essential in motor-simulation research, but no measure of AOMI ability currently exists. Accordingly, the AOMI Ability Questionnaire (AOMI-AQ) was developed to address this gap in the literature. In Study 1, two hundred eleven participants completed the AOMI-AQ and the kinesthetic imagery subscales of the Movement Imagery Questionnaire-3 and Vividness of Motor Imagery Questionnaire-2. Following exploratory factor analysis, an 8-item AOMI-AQ was found to correlate positively with existing motor-imagery measures. In Study 2, one hundred seventy-four participants completed the AOMI-AQ for a second time after a period of 7–10 days. Results indicate a good test–retest reliability for the AOMI-AQ. The new AOMI-AQ measure provides a valid and reliable tool for researchers and practitioners wishing to assess AOMI ability.

11 December 2025 in medRxiv
Verified
Preprint
Open access
PDF file
BHBlair R. Hamilton
Blair R. Hamilton
NMNina Mitic
Nina Mitic
CLCharlotte E. Linscott
Charlotte E. Linscott
KHKe Hu
Ke Hu
MEMaaike Esselaar
Maaike Esselaar
AIAlex Ireland
Alex Ireland
Introduction: Age-related declines in bone and muscle health contribute substantially to frailty, falls, and functional loss in older adults. Despite the established musculoskeletal effects of hormone therapy (HT) in younger transgender and gender diverse women (TGDW), data on ageing TGDW do not exist. TGDW ≥50 years receiving feminising HT exhibit an 80% higher fracture incidence than cisgender adults. This pilot study explored the practicality of community-based recruitment of TGDW receiving HT and provided the first characterisation of musculoskeletal health in this population. Methods: Cross-sectional pilot study recruited forty-eight TGDW aged ≥50 years undergoing feminising HT through two UK community festivals. Body composition (bioelectrical impedance analysis), bone quality (quantitative ultrasound of the radius and tibia), muscle strength and power (handgrip dynamometry, countermovement jump, and 5× sit-to-stand test), and physical activity (IPAQ-SF)were analysed using descriptive statistics, one-sample t-tests against clinical thresholds, and regression models exploring associations between HT duration and musculoskeletal outcomes, adjusting for age, BMI, and physical activity level. Results: Sarcopenia incidence varied from 9% (handgrip strength) to 38% (countermovement jump power), and 38% of participants recorded counter-movement jump power below sarcopenia thresholds, whilst 21% could not complete the sit-to-stand test. Osteoporosis prevalence (8-13%) was higher than in the UK population (5%). Seventy-three per cent of participants were classified as overweight, and 33% classified as obese, higher than UK population norms (26%). Twenty-three per cent of TGDW were classed as physically active compared to their age-matched population (63%). Regression analyses showed no significant association between hormone therapy duration and musculoskeletal outcomes, whereas BMI (countermovement jump power β = 192.1, p adj =0.01; handgrip β = 0.60, p adj =0.02) was a stronger predictor of function. Conclusion: High sarcopenia and osteoporosis prevalence, elevated obesity, and low physical activity highlight areas of concern. Larger longitudinal studies to characterise musculoskeletal ageing using clinical measures are needed. WHAT IS ALREADY KNOWN ON THIS TOPIC: Ageing is associated with declines in bone and muscle health, leading to frailty, falls, and functional loss. Transgender and gender-diverse adults (TGDW) receiving feminising hormone therapy (HT) may experience musculoskeletal changes, but data on those aged ≥50 years are absent. WHAT THIS STUDY ADDS: Provides the first characterisation of musculoskeletal health in ageing TGDW, highlighting osteoporosis and sarcopenia prevalence, substantial variation in bone quality and muscle function, functional limitations in a subset, elevated BMI and reduced physical activity. Demonstrates the feasibility of multi-domain musculoskeletal assessment in this population and identifies BMI and physical activity as stronger determinants of function than hormone therapy duration. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE, OR POLICY: Supports the need for larger longitudinal studies to track musculoskeletal ageing in TGDW. Highlights key modifiable risk factors (BMI, activity) for interventions, informing clinical management and health policy for older TGDW populations.